In experiments on rats, atherogenic diet led to hypercholesterolemia, while addition of verapamil to the diet led to the development of hypertriglyceridemia in these animals. Dyslipidemia induced signifi cant changes in the cardiomyocyte ultrastructure (lytic changes in myofi brils and sarcoplasmic matrix and aggravation of autophagocytosis) that were most pronounced after addition of mercazolyl alone to the diet. After 30-day atherogenic diet, we observed a decrease in the relative content of RyR2 mRNA (by 67-73%, p<0.01) and SERCA2a mRNA (by 75-91%, p<0.01) in the myocardium. In 64 days these parameters remained reduced: by 64-72% (p<0.05) and 54-62% (p<0.05), respectively. Verapamil treatment reduced the severity and number of lytic lesions in cardiomyocytes, induced considerable glycogen accumulation in the sarcoplasm and its sequestration, promoted normalization, and prevented pronounced decrease of the relative RyR2 mRNA and SERCA2a mRNA in rat myocardium.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
L. M. Nepomnyashchikh, E. L. Lushnikova, L. M. Polyakov, et al., Bull. Exp. Biol. Med., 155, No. 5, 692–696 (2013).
E. I. Yuzhik, E. L. Lyshnikova, and M. G. Klinnikova, Fundamental Studies, No. 7–2, 456–464 (2013).
W. H. Barry and J. H. Bridge, Circulation, 87, No. 6, 1806–1815 (1993).
D. M. Bers, Nature, 415, 198–205 (2002).
S. A. Bustin, J. Mol. Endocrinol., 29, No. 1, 23–39 (2002).
M. G. Chelu and X. H. Wehrens, Biochem. Soc. Trans., 35, Pt. 5, 952–956 (2007).
M. Cnop, F. Foufelle, and L. A. Velloso, Trends Mol. Med., 18, No. 1, 59–68 (2012).
E. Grossman and F. H. Messerli, Prog. Cardiovasc. Dis., 47, No. 1, 34–57 (2004).
Y. H uang, K. E. Walker, F. Hanley, et al., Circulation, 109, No. 1, 97–102 (2004).
T. Y. Luo, M. J. Su, Y. F. Yang, et al., J. Biomed. Sci., 11, No. 6, 829–837 (2004).
H. Naegele, B. Behnke, A. Gebhardt, and M. Strohbeck, Clin. Biochem., 31, No. 1, 37–45 (1998).
S. Neef and L. S. Maier, Basic Res. Cardiol., 108, No. 4, 360 (2013).
P. Sallinen, S. Mänttäri, H. Leskinen, et al., Mol. Cell Biochem., 303, No. 2, 97–103 (2007).
D. Terentyev, I. Györke, A. E. Belevych, et al., Circ. Res., 103, No. 12, 1466–1472 (2008).
R. Treinys and J. Jurevicius, Medicina (Kaunas), 44, No. 7, 491–499 (2008).
D. Versari, A. Virdis, L. Ghiadoni, et al., Atherosclerosis, 205, No. 1, 214–220 (2009).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Kletochnye Tekhnologii v Biologii i Meditsine, No. 4, pp. 229–236, October, 2014
Rights and permissions
About this article
Cite this article
Yuzhik, E.I., Lushnikova, E.L., Klinnikova, M.G. et al. Expression of Ryanodine Receptor mRNA and Sarcoplasmic Ca2+-ATPase mRNA in the Myocardium and Intracellular Reorganization of Cardiomyocytes in Dyslipidemia and during Verapamil Treatment. Bull Exp Biol Med 158, 544–550 (2015). https://doi.org/10.1007/s10517-015-2804-1
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-015-2804-1